HON vs IOVA · P/E 36, rev $9.72B vs rev $170.7M
Honeywell International Inc (HON) versus Iovance Biotherapeutics Inc (IOVA) — a side-by-side from cached financials, not a winner call.
Honeywell International Inc (HON) is a conglomerates company listed on NASDAQ. It is led by Vimal Kapur.
Iovance Biotherapeutics Inc (IOVA) is a biotechnology company listed on US.
Latest reported HON revenue for 2026-06-30 was $9.72B. Net income was $5.68B. Revenue was up 6.3% from 2026-03-31 to 2026-06-30. HON currently screens at market cap $144.86B and trailing P/E 36.5.
Latest reported IOVA revenue for 2026-06-30 was $170.7M. Net income was -$126.4M. IOVA currently screens at market cap $1.89B.
HON currently screens at market cap $144.86B and trailing P/E 36.5. IOVA currently screens at market cap $1.89B.
Not investment advice. Open the HON and IOVA stock pages for the full models.
Not investment advice.